CEO and Co-founder
Cellentia, Inc.
Cellentia, Inc., Redwood City, CA (Nov 2022 – Present)
• CEO and Co-Founder: Establish a startup contractor research organization providing boutique bioassay services
BioPillars Consulting LLC, San Francisco Bay Area, CA, and Boston, MA (Aug 2021 – Present)
• Founding Partner: Provides drug development consultation services, specialized in product development of cell and gene therapy and biologics.
Tessa Therapeutics, Singapore and Houston, TX (Nov 2016 – Jul 2021)
• VP, Product Development: Developed strategies and executed plans for product development of cell therapy products and viral vectors.
Kiang Consulting Services, San Francisco Bay Area, California (Jun 2016 – Nov 2016)
• Partner: Provided guidance, developed strategies, and designed key experiments for accelerating product development for biologicals, cell, and gene therapy products.
Merck Sharp & Dohme (Merck), Translational Medicine Research Centre, Singapore (Oct 2009 – May 2015)
• Led a diversified team of scientists in immunoassays, bioassays, flow cytometry, and genomic assays.
• Established a new GLP biomarker lab for molecular biomarkers.
Enterprise Catalyst Group, San Francisco Bay Area, CA (Jan 2009 – Sep 2009)
• Principal Consultant: Provided guidance in product development for biopharmaceuticals.
Cell Genesys, Inc., South San Francisco, CA (2002-2008)
• Held various positions, including Director of Assay Development and Associate Director of Assay Development, leading assay development for cell and gene therapy products.
Bayer Corporation, Pharmaceutical Division, Berkeley, CA (2001-2002)
• Senior Staff Scientist: Developed stable liquid formulations for therapeutic proteins and evaluated novel drug delivery methods.
Aventis Pharmaceuticals (currently sanofi), Hayward, CA (1994-2001)
• Held multiple roles, including Head of Viral Formulation and Senior Research Scientist, focusing on formulation development and assay/process development.
Biosource International (currently Invitrogen), Inc., Burlingame, CA (1993-1994)
• Senior Scientist and Group Leader: Built an efficient purification group for producing research and in vitro diagnostic reagents.